Results
26,451 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 20 |  David J. TaylorRSelf |  PLDPrologis, Inc.Sale | SELL | $1,001 – $15K |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 20 | David J. TaylorRSelf | PLDPrologis, Inc. Sale | SELL | $1,001 – $15K |
| Mar 6, 2026 traded Feb 26, 2026 |
| 20 | Riley JanelChief Accounting Officer |  NETCloudflare, Inc.Open-market sale · 10b5-1 plan | SELL | $4.43M 23.3K sh | Mar 6, 2026 traded Mar 5, 2026 |
| 20 | David J. TaylorRSelf |  MPCMarathon Petroleum CorpSale | SELL | $1,001 – $15K | Mar 6, 2026 traded Feb 26, 2026 |
| 20 | David J. TaylorRSelf |  RPMRPM INTERNATIONAL INC/DE/Sale | SELL | $1,001 – $15K | Mar 6, 2026 traded Feb 26, 2026 |
| 20 |  Byron DonaldsRSelf |  PYPLPayPal Holdings, Inc.Sale | SELL | $1,001 – $15K | Mar 6, 2026 traded Feb 10, 2026 |
| 20 | Byron DonaldsRSpouse | PYPLPayPal Holdings, Inc. Sale | SELL | $1,001 – $15K | Mar 6, 2026 traded Feb 10, 2026 |
| 19 | Kozanian PanosEVP, Product Engineering |  FIVNFive9, Inc.Open-market sale · 10b5-1 plan | SELL | $69K 3,860 sh | Mar 6, 2026 traded Mar 4, 2026 |
| 19 | Lee Bryan MChief Financial Officer | FIVNFive9, Inc. Open-market sale · 10b5-1 plan | SELL | $174K 9,855 sh | Mar 6, 2026 traded Mar 4, 2026 |
| 19 | Fitzpatrick JenniferChief Legal Officer |  SIONSionna Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $347K 10.3K sh | Mar 6, 2026 traded Mar 5, 2026 |
| 19 | Kozanian PanosEVP, Product Engineering | FIVNFive9, Inc. Open-market sale · 10b5-1 plan | SELL | $126K 7,002 sh | Mar 6, 2026 traded Mar 4, 2026 |
| 19 | Dignan AndyPresident | FIVNFive9, Inc. Open-market sale · 10b5-1 plan | SELL | $60K 3,369 sh | Mar 6, 2026 traded Mar 5, 2026 |
| 19 | Dignan AndyPresident | FIVNFive9, Inc. Open-market sale · 10b5-1 plan | SELL | $87K 4,924 sh | Mar 6, 2026 traded Mar 4, 2026 |
| 18 | Reardon AndrewCLO & Secretary |  LGNDLIGAND PHARMACEUTICALS INCOpen-market sale · 10b5-1 plan | SELL | $239K 1,142 sh | Mar 6, 2026 traded Mar 4, 2026 |
| 18 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $94K 460 sh | Mar 6, 2026 traded Mar 4, 2026 |
| 18 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $70K 340 sh | Mar 6, 2026 traded Mar 4, 2026 |
| 18 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $127K 612 sh | Mar 6, 2026 traded Mar 4, 2026 |
| 18 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $61K 300 sh | Mar 6, 2026 traded Mar 4, 2026 |
| 17 | Espinoza OctavioChief Financial Officer | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $300K 1,457 sh | Mar 6, 2026 traded Mar 4, 2026 |
| 16 | David J. TaylorRSelf |  PHParker-Hannifin CorpSale | SELL | $1,001 – $15K | Mar 6, 2026 traded Feb 26, 2026 |
| 16 | David J. TaylorRSelf | PHParker-Hannifin Corp Sale | SELL | $1,001 – $15K | Mar 6, 2026 traded Feb 26, 2026 |
| 16 | Lee Bryan MChief Financial Officer | FIVNFive9, Inc. Open-market sale · 10b5-1 plan | SELL | $31K 1,756 sh | Mar 6, 2026 traded Mar 5, 2026 |
| 15 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $41K 200 sh | Mar 6, 2026 traded Mar 4, 2026 |
| 15 | Mitchell AndreaDirector |  DAVEDave Inc./DEOpen-market sale · 10b5-1 plan | SELL | $411K 1,883 sh | Mar 6, 2026 traded Mar 5, 2026 |
| 15 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $20K 100 sh | Mar 6, 2026 traded Mar 4, 2026 |
| 15 | Mitchell AndreaDirector | DAVEDave Inc./DE Open-market sale · 10b5-1 plan | SELL | $866K 4,029 sh | Mar 6, 2026 traded Mar 5, 2026 |
| 15 | Mitchell AndreaDirector | DAVEDave Inc./DE Open-market sale · 10b5-1 plan | SELL | $389K 1,848 sh | Mar 6, 2026 traded Mar 5, 2026 |
| 15 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $19K 93 sh | Mar 6, 2026 traded Mar 4, 2026 |
| 15 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $20K 100 sh | Mar 6, 2026 traded Mar 4, 2026 |
| 15 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $41K 207 sh | Mar 6, 2026 traded Mar 4, 2026 |
| 14 | Espinoza OctavioChief Financial Officer | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $141K 697 sh | Mar 6, 2026 traded Mar 4, 2026 |
| 14 | Espinoza OctavioChief Financial Officer | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $192K 950 sh | Mar 6, 2026 traded Mar 4, 2026 |
| 14 | Espinoza OctavioChief Financial Officer | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $140K 698 sh | Mar 6, 2026 traded Mar 4, 2026 |
| 14 | Espinoza OctavioChief Financial Officer | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $139K 699 sh | Mar 6, 2026 traded Mar 4, 2026 |
| 14 | Espinoza OctavioChief Financial Officer | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $136K 668 sh | Mar 6, 2026 traded Mar 4, 2026 |
| 14 | Espinoza OctavioChief Financial Officer | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $152K 743 sh | Mar 6, 2026 traded Mar 4, 2026 |
| 13 | Collier CharlesPresident, Roku Media |  ROKUROKU, INCOpen-market sale · 10b5-1 plan | SELL | $172K 1,715 sh | Mar 6, 2026 traded Mar 5, 2026 |
| 11 | Mitchell AndreaDirector | DAVEDave Inc./DE Open-market sale · 10b5-1 plan | SELL | $264K 1,235 sh | Mar 6, 2026 traded Mar 5, 2026 |
| 11 | Espinoza OctavioChief Financial Officer | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $11K 53 sh | Mar 6, 2026 traded Mar 4, 2026 |
| 11 | Mitchell AndreaDirector | DAVEDave Inc./DE Open-market sale · 10b5-1 plan | SELL | $356K 1,685 sh | Mar 6, 2026 traded Mar 5, 2026 |
| 9 | McGuire AnnieSVP, General Counsel |  VCYTVERACYTE, INC.Open-market sale · 10b5-1 plan | SELL | $60K 1,664 sh | Mar 6, 2026 traded Mar 4, 2026 |